[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-detail-344791-en":59,"doc-seo-344791-105":99},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":5,"data":60},{"doc_id":61,"user_id":62,"nickname":63,"user_avatar":64,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":66,"doc_content":67,"file_id":68,"file_url":69,"file_type":70,"file_size":71,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":72,"language":73,"language_code":74,"site_id":75,"html_lang":74,"table_of_contents":76,"faqs":77,"seo_title":78,"seo_description":66,"update_tm":79,"read_time":80,"preview_page_count":19,"preview_urls":81},344791,34359740700684,"Finn","https://ap-avatar.wpscdn.com/avatar/1f400023980c374ae676?_k=1777273430885731487","Precision screening identifies mitoxantrone as a multitarget inhibitor in ageing-associated cancers with extensive computational validation and doxorubicin comparison","Ageing-associated cancers are driven by persistent DNA damage and tumour-cell escape from senescence checkpoints, promoting genomic instability and uncontrolled proliferation. This study performed protein-target identification and docking of Extra Precision and MM-GBSA workflows against the FDA-approved DrugBank library, comparing results with doxorubicin. Mitoxantrone showed top docking and MM-GBSA scores across multiple target proteins, supported by interaction fingerprint residues, pharmacokinetic and DFT computations, WaterMap hydration-site analysis, and 100 ns molecular dynamics stability with binding-free energy and total-complex energy assessments.","OPEN ACCESS  \nCitation: Al-Qahtani MH, Assidi M, Buhmeida A, Almuhammadi A, Pushparaj PN, Alganmi NA (2026) Precision screening identifies mitoxantrone as a multitarget inhibitor in ageing-associated cancers with extensive computational validation and doxorubicin comparison. PLoS One 21(2):  \ne0341446. [https://doi.org/10.1371/journal](https://doi.org/10.1371/journal). pone.0341446  \nEditor: Chandrabose Selvaraj, AMET University, INDIA  \nReceived: October 31, 2025  \nAccepted: January 7, 2026  \nPublished: February 13, 2026  \nPeer Review History: PLOS recognizes the benefits of transparency in the peer review process; therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. The editorial history of this article is available here: [https://doi.org/10.1371/journal](https://doi.org/10.1371/journal). pone.0341446  \nCopyright: © 2026 Al-Qahtani et al. This is an open access article distributed under the terms  \nRESEARCH ARTICLE  \nPrecision screening identifies mitoxantroneas a multitarget inhibitor in ageing-associated cancers with extensive computational validation and doxorubicin comparison  \nMohammed H. Al-Qahtani1,2*, Mourad Assidi1,2, Abdelbaset Buhmeida1,2, Asma Almuhammadi3, Peter Natesan Pushparaj1,2, Nofe Ateq Alganmi1,4  \n1 Institute of Genomic Medicine Sciences, King Abdulaziz University, Jeddah, Saudi Arabia, 2 Department of Medical Lab Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia, 3 Department of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia, 4 Computer Science Department, Faculty of Computing and Information Technology, King Abdulaziz University, Jeddah, Saudi Arabia  \n* [mhalqahtani@kau.edu.sa](mhalqahtani@kau.edu.sa), [qahtani_i@hotmail.com](qahtani_i@hotmail.com)  \nAbstract  \nAgeing-associated cancers are characterised by the dual hallmarks of persistent DNA damage and the ability of tumour cells to escape senescence checkpoints, which drive genomic instability and uncontrolled proliferation. In this study, we identified crucial proteins with PDB IDs—2YEX (Chk1 kinase), 4HG7 (MDM2 E3 ubiquitin ligase), 4JSX (mTOR kinase domain), and 5DS3 (PARP-1 DNA repair enzyme)—involved in ageing-related cancers and performed docking studies with Extra Precision (XP) followed by MM-GBSA-based pose processing against the FDA-approved DrugBank library (LigPrep: 10907 compounds) . The extensive docking computations identified many good candidates; however, Mitoxantrone emerges as the topmost candidate with docking scores of −6.23 to −16.044 Kcal/mol and MM-GBSA score of −49.19 to −85.14 Kcal/mol, which currently is being used to treat advanced prostate cancer and acute nonlymphocytic leukaemia (ANLL) and would be easier to repurpose to other ageing-related cancers. Mitoxantrone also emerges as a better candidate compared to the control drug Doxorubicin. Further, the complex of all 4 proteins with Mitoxantrone was taken for interaction fingerprints and found that the most interacting residues with counts were 6GLY, 6VAL, 5GLU, 5LEU, 4ALA, 3ASP, and 3TYR, among others. The pharmacokinetics and Density Functional Theory computations further support Mitoxantrone as a potential candidate. We also performed a 5-nanoseconds (ns) WaterMap for hydration site identification and the role of water in stabilisation of the complex, followed by a 100 ns MD Simulation that resulted in stable deviation and fluctuations mostly under \u003C2Å and a web of simulation interactions making the complex stable. Furthermore, the same trajectories were used for the Binding Free and Total Complex Energies computations, revealing that the complexes were  \nPLOS One | [https://doi.org/10.1371/journal.pone.0341446](https://doi.org/10.1371/journal.pone.0341446) February 13, 2026 1 / 33  \nof the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any med","cbCairD53c6F0CiJ","https://ap.wps.com/l/cbCairD53c6F0CiJ","pdf",5842218,33,"English","en",105,"# Abstract\n## Computational screening and docking\n## MM-GBSA validation and comparison\n## Interaction fingerprints and residue analysis\n## Pharmacokinetics, DFT, and simulation stability","[{\"question\":\"Which protein targets were screened in the study?\",\"answer\":\"The study focused on proteins identified by PDB IDs: 2YEX (Chk1 kinase), 4HG7 (MDM2 E3 ubiquitin ligase), 4JSX (mTOR kinase domain), and 5DS3 (PARP-1 DNA repair enzyme).\"},{\"question\":\"How was mitoxantrone evaluated as a candidate?\",\"answer\":\"Mitoxantrone was ranked using docking with Extra Precision followed by MM-GBSA-based pose processing against the DrugBank library, and it was compared directly with doxorubicin.\"},{\"question\":\"What computational analyses support the stability and mechanism of the mitoxantrone-protein complexes?\",\"answer\":\"The work included interaction fingerprint residue counts, pharmacokinetics and DFT computations, WaterMap hydration-site identification, and 100 ns molecular dynamics showing mostly sub-2 Å deviations and fluctuations, followed by binding-free and total complex energy calculations.\"}]","Precision screening identifies mitoxantrone as a multitarget inhibitor in ageing-associated cancers with extensive computational validation and doxorubicin comparison | PDF",1790055279,83,[82,86,90,95],{"page_no":8,"url":83,"width":84,"height":85},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/836f3b6edf96c523527616904ccb9057.webp",983,1272,{"page_no":14,"url":87,"width":88,"height":89},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2247d70a37f6680bccddc9e755f8853e.webp",982,1270,{"page_no":91,"url":92,"width":93,"height":94},3,"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c0eea3648a72a3521c073e47052bba15.webp",981,1269,{"page_no":19,"url":96,"width":97,"height":98},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/afde3d087f1cc19dc28982977d125575.webp",980,1268,{"code":4,"msg":100,"data":101},"ok",{"site_id":75,"language":74,"slug":102,"title":65,"keywords":103,"description":66,"schema_data":104,"social_meta":157,"head_meta":159,"extra_data":161,"updated_unix":162},"precision-screening-identifies-mitoxantrone-as-a-multitarget-inhibitor-in-ageing-associated-cancers-with-extensive-computational-validation-and-doxorubicin-comparison","",{"@graph":105,"@context":156},[106,119,139],{"@type":107,"itemListElement":108},"BreadcrumbList",[109,113,115,117],{"item":110,"name":111,"@type":112,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":114,"name":9,"@type":112,"position":14},"https://docshare.wps.com/document/",{"item":116,"name":40,"@type":112,"position":91},"https://docshare.wps.com/document/research-report/",{"item":118,"name":65,"@type":112,"position":19},"https://docshare.wps.com/document/precision-screening-identifies-mitoxantrone-as-a-multitarget-inhibitor-in-ageing-associated-cancers-with-extensive-computational-validation-and-doxorubicin-comparison/344791/",{"url":118,"name":65,"@type":120,"image":121,"author":126,"headline":65,"publisher":128,"fileFormat":131,"inLanguage":74,"description":66,"dateModified":132,"datePublished":133,"encodingFormat":131,"isAccessibleForFree":134,"interactionStatistic":135},"DigitalDocument",{"url":122,"@type":123,"width":124,"height":125},"https://docshare.wps.com/thumbnails/precision-screening-identifies-mitoxantrone-as-a-multitarget-inhibitor-in-ageing-associated-cancers-with-extensive-computational-validation-and-doxorubicin-comparison/344791.png","ImageObject",300,407,{"name":63,"@type":127},"Person",{"url":110,"name":129,"@type":130},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":136,"interactionType":137,"userInteractionCount":34},"InteractionCounter",{"@type":138},"ViewAction",{"@type":140,"mainEntity":141},"FAQPage",[142,148,152],{"name":143,"@type":144,"acceptedAnswer":145},"Which protein targets were screened in the study?","Question",{"text":146,"@type":147},"The study focused on proteins identified by PDB IDs: 2YEX (Chk1 kinase), 4HG7 (MDM2 E3 ubiquitin ligase), 4JSX (mTOR kinase domain), and 5DS3 (PARP-1 DNA repair enzyme).","Answer",{"name":149,"@type":144,"acceptedAnswer":150},"How was mitoxantrone evaluated as a candidate?",{"text":151,"@type":147},"Mitoxantrone was ranked using docking with Extra Precision followed by MM-GBSA-based pose processing against the DrugBank library, and it was compared directly with doxorubicin.",{"name":153,"@type":144,"acceptedAnswer":154},"What computational analyses support the stability and mechanism of the mitoxantrone-protein complexes?",{"text":155,"@type":147},"The work included interaction fingerprint residue counts, pharmacokinetics and DFT computations, WaterMap hydration-site identification, and 100 ns molecular dynamics showing mostly sub-2 Å deviations and fluctuations, followed by binding-free and total complex energy calculations.","https://schema.org",{"og:url":118,"og:type":158,"og:title":65,"og:site_name":129,"og:description":66},"article",{"robots":160,"canonical":118},"index,follow",{"doc_id":61,"site_id":75},1791123500]